Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 146,200 | 719,200 | 778,600 | 752,900 | 760,000 |
| Depreciation Amortization | 712,400 | 375,800 | 358,500 | 459,100 | 359,900 |
| Income taxes - deferred | -164,000 | -90,500 | -126,200 | -64,800 | -19,700 |
| Accounts receivable | -56,100 | -40,400 | -74,300 | -45,500 | -63,200 |
| Other Working Capital | -290,600 | 12,300 | -134,100 | -63,400 | -3,100 |
| Other Operating Activity | 501,900 | 84,100 | 160,600 | 113,600 | 143,000 |
| Operating Cash Flow | $849,800 | $1,060,500 | $963,100 | $1,151,900 | $1,176,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -214,800 | -1,350,900 | 98,100 | -251,600 | -267,300 |
| PPE Investments | -434,100 | -342,300 | -292,900 | -263,600 | -269,200 |
| Net Acquisitions | -7,690,200 | N/A | N/A | -59,000 | -56,800 |
| Sale Of Investment | 802,900 | 1,282,200 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -54,300 | -74,200 | N/A | N/A |
| Other Investing Activity | -21,700 | -58,400 | -87,700 | -17,900 | -31,100 |
| Investing Cash Flow | $-7,557,900 | $-469,400 | $-282,500 | $-592,100 | $-624,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 0 | 0 | 549,300 |
| Debt Issued | 10,628,200 | -247,700 | -97,500 | 97,200 | 500 |
| Debt Repayment | -3,261,900 | 0 | 0 | 0 | N/A |
| Common Stock Issued | 105,200 | 284,700 | 474,800 | 46,900 | 43,400 |
| Common Stock Repurchased | -150,000 | -400,900 | -720,800 | -485,600 | -1,050,000 |
| Dividend Paid | -157,100 | -145,500 | -132,400 | -94,400 | N/A |
| Other Financing Activity | -57,700 | -60,700 | 8,600 | -600 | 1,000 |
| Financing Cash Flow | $7,106,700 | $-570,100 | $-467,300 | $-436,500 | $-455,800 |
| Exchange Rate Effect | -22,600 | -18,300 | -17,000 | -7,300 | 2,700 |
| Beginning Cash Position | 1,083,300 | 1,080,600 | 884,300 | 768,300 | 668,900 |
| End Cash Position | 1,459,300 | 1,083,300 | 1,080,600 | 884,300 | 768,300 |
| Net Cash Flow | $376,000 | $2,700 | $196,300 | $116,000 | $99,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 849,800 | 1,060,500 | 963,100 | 1,151,900 | 1,176,900 |
| Capital Expenditure | -434,100 | -342,300 | -292,900 | -263,600 | -155,400 |
| Free Cash Flow | 415,700 | 718,200 | 670,200 | 888,300 | 1,021,500 |